Zoetis to Acquire Neogen’s Animal Genomics Business for $160 Million
March 3, 2026
Zoetis announced it has entered into a definitive agreement to acquire Neogen Corporation’s animal genomics business for $160 million, subject to customary closing adjustments. The deal is intended to strengthen Zoetis’ leadership in Precision Animal Health by integrating Neogen’s genomic technologies and data solutions to expand predictive insights and individualized care.
- Buyers
- Zoetis
- Targets
- Neogen Corporation (animal genomics business)
- Sellers
- Neogen Corporation
- Industry
- Healthcare Services
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
QIAGEN Acquires Genoox
May 12, 2025
Biotechnology
QIAGEN has signed a definitive agreement to acquire Genoox, the developer of the AI-powered Franklin clinical genomics platform, for $70 million in cash plus up to $10 million in milestone payments. The acquisition adds Genoox's cloud-based AI interpretation capabilities to QIAGEN Digital Insights, expanding QIAGEN's clinical genomics and diagnostic software offerings for labs and healthcare organizations worldwide.
-
AstraZeneca Acquires Neogene Therapeutics
November 29, 2022
Biotechnology
AstraZeneca has agreed to acquire Neogene Therapeutics, a clinical-stage biotechnology company focused on next-generation T-cell receptor (TCR) therapies, for up to $320 million. The acquisition strengthens AstraZeneca's oncology cell therapy capabilities by adding Neogene's discovery, development and manufacturing expertise for TCR-Ts targeting solid tumours.
-
Eurobio Scientific Acquires GenDx (Genome Diagnostics B.V.)
October 4, 2022
Biotechnology
Paris-based Eurobio Scientific has acquired all outstanding shares of Dutch transplant diagnostics specialist GenDx (Genome Diagnostics B.V.), following a share purchase agreement signed on August 17. The acquisition expands Eurobio's molecular diagnostics portfolio in transplantation and secures the company legacy with proceeds funding a GenDx foundation established by the founders.
-
Zoetis Acquires Basepaws to Expand Precision Petcare Genetics and Diagnostics
June 7, 2022
Healthcare Services
Zoetis agreed to acquire Basepaws, a privately held petcare genetics company that provides genetic tests, analytics, and early health risk assessments for pets. Zoetis said the deal will strengthen its precision animal health portfolio and inform its future petcare R&D pipeline using Basepaws’ feline genomic and microbiome database.
-
Neogen Acquires CAPInnoVet, Inc.
September 20, 2021
Pharmaceuticals
Neogen Corporation has acquired Atlanta-based CAPInnoVet, Inc., a companion animal health company that provides pet medications to the veterinary market. The acquisition gives Neogen entry into the retail parasiticide market and will integrate CAPInnoVet into Neogen's Animal Safety business segment; terms were not disclosed.
-
Twist Bioscience Acquires iGenomX
June 30, 2021
Biotechnology
Twist Bioscience acquired iGenomX, a developer of high-throughput multiplex NGS library preparation tools, to expand its NGS workflow capabilities and accelerate customer conversion from microarray genotyping to sequencing-based genotyping. The deal consideration was $35 million (combination of cash and Twist stock, plus up to $5 million contingent stock), and Twist expects modest near-term financial impact with incremental revenue from the acquired business in fiscal 2023.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.